US Patent Issued to DOUGLAS PHARMACETICALS on July 8 for "Extended release pharmaceutical formulation and methods of treatment" (New Zealander Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,378, issued on July 8, was assigned to DOUGLAS PHARMACETICALS LTD (Auckland, New Zealand).

"Extended release pharmaceutical formulation and methods of treatment" was invented by Paul William Glue (Dunedin, New Zealand), Natalie June Medlicott (Dunedin, New Zealand) and Peter William Surman (Auckland, New Zealand).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides an oral extended release formulation for the treatment of treatment-resistant depression, treatment-resistant anxiety, and phobia."

The patent was filed on June 28, 2022, under Application No. 17/851,451.

*For further information, including images, charts and tables, plea...